News

Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...
The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...
One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.
Assembly Biosciences has dosed the first subject in the Phase Ia/b study’s Phase Ib portion, evaluating ABI-1179.
A key viral mechanism that allows HSV-1 to evade the brain’s natural defenses has been uncovered and tested to identify new treatments.
Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus the standard of care treatments Acyclovir and Abreva in a preclinical animal model. Toronto ...
The valacyclovir dose for cold sores is different from the dose for herpes, and the dose also depends on whether this is your first rodeo or if you’ve experienced outbreaks before.
Medically reviewed by William Truswell, MD Cold sores and pimples are two common skin conditions that primarily affect the face. Cold sores (herpes labialis) are caused by the herpes simplex virus ...
This Press Release updates numerical list in reference section. Theralase ® validates previous University of Manitoba research by demonstrating that Ruvidar TM is safe and effective in the ...
Revolutionizing Long-Term Relief with Affordable and Scalable Solutions for Herpes Simplex Virus (HSV) Patients By leveraging the proven safety and accessibility of GRAS/E OTCs, we’re on track ...
Theralase ® validates previous University of Manitoba research by demonstrating that Ruvidar TM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model.. TORONTO, ON ...
Revolutionizing Long-Term Relief with Affordable and Scalable Solutions for Herpes Simplex Virus (HSV) Patients By leveraging the proven safety and accessibility of GRAS/E OTCs, we’re on track ...